OnePlus Technology (Shenzhen) Co., Ltd. et al. v. Pantech Corporation

IPR2025-00762

OnePlus has filed an IPR petition challenging Pantech’s 10,863,573 patent covering dual‑connectivity data handling. The petition asserts obviousness over three prior‑art references and seeks institution and cancellation of claims 1‑5 and 8‑12.

Jurisdiction
US PTAB
Case Number
IPR2025-00762
Filing Date
24 April 2025
Status
ok

Related Cases

patentIPR2025-00755

USAA Federal Savings BankvsPACid Technologies, LLC

USAA Federal Savings Bank and PACid Technologies have jointly moved to terminate IPR2025-00755 after resolving their dispute in district court, invoking 35 U.S.C. § 317(a).

patentIPR2025-00931

American Airlines, Inc. et al.vsIntellectual Ventures II LLC

American Airlines and Southwest Airlines failed to convince the PTAB that Intellectual Ventures' claims regarding distributed OS image management were unpatentable. The Board denied institution, finding the petitioner did not meet the reasonable likelihood standard against combinations of prior art references.

patentIPR2024-00934

Texas Instruments IncorporatedvsParkerVision, Inc.

Texas Instruments (TI) successfully secured the institution of its IPR against ParkerVision, Inc., establishing a reasonable likelihood of prevailing on obviousness grounds. The Board found that TI's evidence was sufficient at this stage to overcome arguments regarding inherency and simulation data reliability.

patentIPR2024-00485

Juniper Networks, Inc.vsMonarch Networking Solutions LLC

The PTAB issued a final decision finding all 10 claims unpatentable based on obviousness over prior art references Li and Wu. The Board adopted the Petitioner's definition of 'domain,' which was crucial to establishing the combination of teachings from both sources.

patentPGR2025-00039

Merck Sharp & Dohme LLCvsHalozyme, Inc. et al.

Merck’s petition reply contends that Halozyme’s hyaluronidase enzyme patent fails the written‑description and enablement requirements of 35 U.S.C. §112(a). The company argues the disclosed genus is too broad and impossible to enable without undue experimentation.

Arctic Invent — IP Strategy

Dealing with a patent challenge?

Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.

Talk to our patent team →

Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.

Strategy Consult

Facing a similar patent matter?

Arctic's litigation team uses precedent data like this to build winning arguments.

Get a Strategy Call